Abstract
Background and Aims : It has been reported that P-selectin, a marker of platelet activation, is associated with denser fibrin networks in coronary artery disease (CAD). It is unclear whether high-intensity statin therapy reduces P-selectin levels and such changes can affect the fibrin clot phenotype in CAD patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
